These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29102437)

  • 21. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Escaned J; Collet C; Ryan N; De Maria GL; Walsh S; Sabate M; Davies J; Lesiak M; Moreno R; Cruz-Gonzalez I; Hoole SP; Ej West N; Piek JJ; Zaman A; Fath-Ordoubadi F; Stables RH; Appleby C; van Mieghem N; van Geuns RJ; Uren N; Zueco J; Buszman P; Iñiguez A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; Hanratty C; Cavalcante R; Kappetein AP; Taggart DP; van Es GA; Morel MA; de Vries T; Onuma Y; Farooq V; Serruys PW; Banning AP
    Eur Heart J; 2017 Nov; 38(42):3124-3134. PubMed ID: 29020367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients.
    Sá MP; Ferraz PE; Escobar RR; Nunes EO; Soares AM; Araújo e Sá FB; Vasconcelos FP; Lima RC
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):83-92. PubMed ID: 23739937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients.
    Alam M; Huang HD; Shahzad SA; Kar B; Virani SS; Rogers PA; Paniagua D; Bozkurt B; Palacios I; Kleiman NS; Jneid H
    Circ J; 2013; 77(2):372-82. PubMed ID: 23123552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
    Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
    J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.
    Zhang J; Jiang T; Hou Y; Chen F; Yang K; Sang W; Wu H; Ma Y; Xu F; Chen Y
    Atherosclerosis; 2020 Sep; 308():50-56. PubMed ID: 32713512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-Analysis Comparing Coronary Artery Bypass Grafting to Drug-Eluting Stents and to Medical Therapy Alone for Left Main Coronary Artery Disease.
    Shah R; Morsy MS; Weiman DS; Vetrovec GW
    Am J Cardiol; 2017 Jul; 120(1):63-68. PubMed ID: 28532780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Takagi H; Ando T; Umemoto T;
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):697-709. PubMed ID: 28799701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis.
    Gallo M; Blitzer D; Laforgia PL; Doulamis IP; Perrin N; Bortolussi G; Guariento A; Putzu A
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):94-105.e15. PubMed ID: 32499076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Qian C; Feng H; Cao J; Wei B; Wang Y
    Am J Cardiol; 2017 May; 119(9):1338-1343. PubMed ID: 28267960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
    Buchanan GL; Chieffo A; Meliga E; Mehran R; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Allgar V; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    Am J Cardiol; 2014 Apr; 113(8):1348-55. PubMed ID: 24581924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
    Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis.
    Zhou JY; Tie EN; Liew D; Duffy SJ; Shaw J; Walton A; Chan W; Stub D
    Heart Lung Circ; 2022 May; 31(5):658-665. PubMed ID: 35033432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.
    De Rosa S; Polimeni A; Sabatino J; Indolfi C
    BMC Cardiovasc Disord; 2017 Sep; 17(1):240. PubMed ID: 28877676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry.
    Lee PH; Lee JY; Lee CW; Han S; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am Heart J; 2017 Nov; 193():76-83. PubMed ID: 29129258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.